Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Telmisartan, ramipril, or both in patients at high risk of vascular events.

Telmisartan, ramipril, or both in patients at high risk of vascular events. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Telmisartan, ramipril, or both in patients at high risk of vascular events. Abstract Text:

    Telmisartan, ramipril, or both in patients at high risk of vascular events. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Telmisartan, ramipril, or both in patients at high risk of vascular events. Journal Published:

    PUBLICATION TYPE: Letter

    Journal: The New England journal of medicine

    VOLUME: 359

    Page Numbers: 426

    Journal Abbreviation: N. Engl. J. Med.

    ISSN: 1533-4406

    DAY: 24

    MONTH: Jul

    YEAR: 2008

    Telmisartan, ramipril, or both in patients at high risk of vascular events. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 255562

    Telmisartan, ramipril, or both in patients at high risk of vascular events. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Telmisartan, ramipril, or both in patients at high risk of vascular events. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Telmisartan, ramipril, or both in patients at high risk of vascular events.

    AFFILIATION:

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: N Engl J Med

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Telmisartan, ramipril, or both in patients at high risk of vascular events Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News